Cargando…
Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
Autores principales: | Harmening, Kathrin, Heile, Anna, Miller, Miles, Johanson, Conrad E, Wallrapp, Christine, Brinker, Thomas, Silverberg, Gerald D, Klinge, Petra M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786122/ http://dx.doi.org/10.1186/1743-8454-6-S2-S15 |
Ejemplares similares
-
Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1
por: Heile, Anna, et al.
Publicado: (2011) -
Therapeutic concentrations of glucagon-like peptide-1 in cerebrospinal fluid following cell-based delivery into the cerebral ventricles of cats
por: Glage, Silke, et al.
Publicado: (2011) -
Multiplicity of cerebrospinal fluid functions: New challenges in health and disease
por: Johanson, Conrad E, et al.
Publicado: (2008) -
Periventricular destabilization and ventriculomegaly in aging rats: implications for reduced neurogenesis and cognition
por: Johanson, Conrad, et al.
Publicado: (2009) -
Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications
por: Heile, Michael, et al.
Publicado: (2018)